Clinical Trials Directory

Trials / Unknown

UnknownNCT03890835

Pulpotomy in Mature Permanent Molars Using Biodentine Versus MTA

Comparative Evaluation of Postoperative Pain and Success Rate After Pulpotomy in Mature Permanent Molars Using Biodentine Versus Mineral Trioxide Aggregate (MTA) as Capping Materials: A Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare treatment outcomes of pulpotomy in mature permanent teeth using Biodentine versus MTA regarding postoperative pain and success rate.

Detailed description

* Patients will be clinically and radiographically examined and their eligibility will be assessed. * Eligible patients will be randomly assigned to one of 2 groups: experimental group (pulpotomy using Biodentine) and the control group (pulpotomy using MTA). * After adminsrtation of local anesthesia, pulpotomy will be done under rubber dam isolation. The pulp tissue will be removed until the level of the orifices of the canals. After hemostasis is achieved, the capping material will be placed. In the experimental group, the capping material is Biodentine while in the control group, the capping material is MTA * The cavities will be sealed with resin-modified glass ionomer. Then the teeth will be permanently restored with composite . A post-operative radiograph will be taken. * The patients will be given a pain diary based on Numerical Rating Scale (NRS) and asked to rate their pain level at the specified times. * The patients will be recalled after 6 and 12 months post-operatively.

Conditions

Interventions

TypeNameDescription
PROCEDUREMTA Pulpotomy.Pulpotomy using MTA.
PROCEDUREBiodentine PulpotomyPulpotomy using Biodentine

Timeline

Start date
2019-05-01
Primary completion
2020-05-01
Completion
2020-05-01
First posted
2019-03-26
Last updated
2019-03-26

Source: ClinicalTrials.gov record NCT03890835. Inclusion in this directory is not an endorsement.